IPP Bureau
Healthcare Triangle appoints Sujatha Ramesh as COO
By IPP Bureau - March 20, 2025
Previously, Sujatha has held leadership positions at prominent organizations, including Publicis Sapient, Infinite Computer Solutions, and Capgemini
Entero launches ‘HealthEdge’ programme to empower Retail Chemists
By IPP Bureau - March 20, 2025
UFlex’s FlexiTubes to showcase sustainable beauty packaging at COSMOPROF Italy 2025
By IPP Bureau - March 20, 2025
FlexiTubes will showcase range of eco-friendly and innovative tube options
Aerogen opens India HQ in New Delhi
By IPP Bureau - March 20, 2025
The new office in New Delhi marks a significant funding in the APAC region and reinforces the company’s commitment to advancing respiratory care in India
Croda opens advanced lipids manufacturing facility in Pennsylvania
By IPP Bureau - March 19, 2025
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
Financial Times names Indegene among high-growth companies in Asia-Pacific 2025
By IPP Bureau - March 19, 2025
Indegene combines deep healthcare expertise with a digital-first approach to help pharma, biotech and medical device companies commercialize their products
Zydus receives final approval from USFDA for Apalutamide Tablets, 60 mg
By IPP Bureau - March 19, 2025
Apalutamide is an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-sensitive prostate cancer
Anupriya Patel inaugurates India Innovation Summit – Pioneering Solutions to End TB
By IPP Bureau - March 19, 2025
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
Clariant unveils natural preservation blend for cosmetics 'Nipaguard SCE Vita'
By IPP Bureau - March 19, 2025
Nipaguard SCE Vita delivers comprehensive antimicrobial protection for personal care formulations
Briefs: Zydus, Alkem Laboratories, Alkem Medtech and Relonchem
By IPP Bureau - March 19, 2025
Alkem Medtech to acquire 100% stake of Bombay Ortho
RedHill Biopharma to submit FDA-approved Talicia for UK marketing authorisation
By IPP Bureau - March 19, 2025
Talicia is also approved and launched in the UAE and additional countries may accept UK MHRA approvals as a reference for their own marketing approval processes
Shilpa Biologicals partners with mAbTree Biologics AG for a novel immunooncology asset
By IPP Bureau - March 18, 2025
This program aims to develop a fully human monoclonal antibody against a novel immune checkpoint protein that enables T cell activation
Lupin receives tentative approval from USFDA for Amifampridine Tablets
By IPP Bureau - March 18, 2025
Amifampridine Tablets, 10 mg are indicated for the treatment of Lambert-Eaton myasthenic syndrome in adults and pediatric patients 6 years of age and older.
Morepen launches Empamore for diabetes care with affordable treatment
By IPP Bureau - March 18, 2025
Empamore is poised to make a significant impact by offering high-quality treatment at an affordable price point, empowering millions of Indians to take control of their health
Dr. Reddy's issues nationwide recall of Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL in US
By IPP Bureau - March 18, 2025
The product is being recalled because the infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL single-dose bag, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 m
